Effect of Hemoglobin Variants (Hb J, Hb G, and Hb E) on HbA1c Values as Measured by Cation-Exchange HPLC (Diamat)

Authors:

Abstract
Hemoglobin A1c (HbA1c) is used for the long-term management of patients with diabetes mellitus (DM) (1)(2). Hb variants other than HbA1c and ε-N-lysine-glycated Hb A0 may cause analytical interference in determinations of HbA1c (3)(4)(5)(6). In one study, the authors estimated the prevalence of thalassemia in Taiwan as 7%; moreover, ∼1% of the people in northern Taiwan are β-thalassemia heterozygotes (7). The occurrence of 24 abnormal Hbs (13 α-chain variants and 11 β-chain variants), including Hb G-Taipei, in populations in the Silk Road area of Northwestern China has been presented in a review (8). The frequency of thalassemia has been estimated to be ∼1 in 2350 in Japan (9) and even higher in North Africa (10). Hb E is the second most prevalent Hb variant worldwide and the third most prevalent variant in the US, after Hb S and C. Hb E is found primarily in Southeast Asia, especially among the Thai population (11). In the northeastern region of India, the gene frequency of Hb E is 10.9% (12). In a study of 222 000 blood samples in Canada, 23 cases of Hb J were identified (13). Given that the majority of hemoglobinopathic cases are from families of Asian, Southeast Asian, and Asian Indian ancestry (7)(8)(9)(10)(11)(12)(14)(15)(16), the aim of this study was to investigate the influence of selected Hb structural variants on HbA1c values measured by cation-exchange HPLC.

This publication has 12 references indexed in Scilit: